Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by susanuon Apr 06, 2015 10:58pm
188 Views
Post# 23602755

RE:Warrants

RE:WarrantsNobody has to exercise these warrants at this time - they have until Dec 15, 2015 to do that.

The shares they bought in the financing are eligible to be sold April 11 on.

Some people will not sell their shares and may or may not purchase more shares using
their warrants.

Some people will sell their shares and may or may not purchase more shares using their
warrants.

There is no reason to assume all the shares will be sold and there is no reason to assume
shares will be bought with all the warrants and those shares will be sold.

All those who were in on the financing will proceed as they see fit. 

To take risk off the table, I would sell my shares and wait to exercise my warrants as long as possible to see if the company is producing revenue and then I would evaluate whether it is worthwhile to buy shares with the warrants.

If I were firmly convinced this company will succeed then I would not sell my shares and I
would exercise my warrants to help the company with more money to carry out their business.

So either one or the other above or somewhere in between. 

All placees in the financing will choose depending upon their financial situation and risk tolerance.   Insiders who bought in the financing may sell their shares to get the funds to exercise the warrants to put funds into the company (and pay taxes on the sell).  After exercising the warrants they may sell their shares for reasons only known to them. 

This is April and income taxes are due April 30 in Canada and I think Apr 15 in the U.S.


Bullboard Posts